4D Molecular Therapeutics, Inc.44

4D Molecular Therapeutics, Inc.

4,64USDR
−0,03−0,64%
Alla chiusura del 22 feb, 00:26 GMT
USD
Nessun attività
Visualizza sui grafici
Indietro

Totale spese operative su 4D Molecular Therapeutics, Inc..

Dati annuali
2018
2019
2020
2021
2022
2023
TTM
‪‪−140,00 M‬‬
‪‪−105,00 M‬‬
‪‪−70,00 M‬‬
‪‪−35,00 M‬‬
‪0,00‬
Periodo
Valore
Variazione
Variazione %
TTM
2023
‪‪−133,59 M‬‬
‪‪−20,43 M‬‬
‪−18,05‬%
2022
‪‪−113,16 M‬‬
‪‪−23,79 M‬‬
‪−26,62‬%
2021
‪‪−89,37 M‬‬
‪‪−19,09 M‬‬
‪−27,17‬%
2020
‪‪−70,28 M‬‬
‪‪−12,53 M‬‬
‪−21,69‬%
2019
‪‪−57,75 M‬‬
‪‪−33,22 M‬‬
‪−135,44‬%
2018
Dati trimestrali
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−60,00 M‬‬
‪‪−45,00 M‬‬
‪‪−30,00 M‬‬
‪‪−15,00 M‬‬
‪0,00‬
Periodo
Valore
Variazione
Variazione %
Q3 '24
‪‪−51,13 M‬‬
‪‪−8,67 M‬‬
‪−20,43‬%
Q2 '24
‪‪−42,46 M‬‬
‪‪−4,30 M‬‬
‪−11,26‬%
Q1 '24
‪‪−38,16 M‬‬
‪‪−3,99 M‬‬
‪−11,66‬%
Q3 '23
‪‪−34,18 M‬‬
‪‪−1,80 M‬‬
‪−5,57‬%
Q2 '23
‪‪−32,38 M‬‬
‪‪−1,97 M‬‬
‪−6,48‬%
Q1 '23
‪‪−30,40 M‬‬
‪‪−437,00 K‬‬
‪−1,46‬%
Q4 '22
‪‪−29,97 M‬‬
‪‪−2,97 M‬‬
‪−11,01‬%
Q3 '22
‪‪−27,00 M‬‬
+‪‪1,59 M‬‬
+‪5,57‬%
Q2 '22
Q1 '22
Q4 '21
Q3 '21
Q2 '21
Q1 '21
Q3 '20
Q2 '20
Q1 '20
Q4 '19